CDC42 and atherosclerosis: Takashi K. Ito et al. revealed that the CDC42 pathway contributes significantly to chronic inflammation related to endothelial cell senescence, and endothelial-specific deletion of CDC42 markedly relieves the endothelial inflammatory response and the progression of atherosclerosis in atherosclerotic mice [36].